MWM
BIIB icon

Modern Wealth Management’s Biogen BIIB Stock Holding History

Modern Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$281K Sell
1,529
-4
-0.3% -$737 ﹤0.01% 737
2025
Q4 		$270K Buy
1,533
+26
+2% +$4.25K ﹤0.01% 715
2025
Q3 		$211K Buy
+1,507
New +$204K ﹤0.01% 754

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Modern Wealth Management's BIIB Position: Q1 2026 in Review

Modern Wealth Management reduced its Biogen (BIIB) stake by 0.26% in Q1 2026, selling an estimated $737 and leaving 1,529 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #737.

Modern Wealth Management first reported a position in BIIB in Q3 2025 and has held it in 3 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Modern Wealth Management held 1,529 shares of Biogen worth $281K as of Q1 2026.
  • Modern Wealth Management sold 4 Biogen shares in Q1 2026, an estimated $737.
  • Biogen made up ﹤0.01% of Modern Wealth Management's portfolio in Q1 2026, its #737 holding.
  • Modern Wealth Management first reported a position in Biogen in Q3 2025 and has held it in 3 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Modern Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.